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Abstract 
Background: Recent interest has demonstrated the nucleus accumbens(NAcc) as a potential 
target for the treatment of depression with DBS.  
 
Introduction: This study sought to demonstrate that DBS of the NAcc is an effective treatment 
modality for  depression and that there is chemical and  
structural changes associated with these behavioral changes that are markers of neuroplasticity. 
 
Methods A deep brain stimulator was placed in the NAcc of male Wistar-Kyoto rats. Groups 
were divided into sham(no stimulation), intermittent(3 hrs/day for two weeks) or  
chronic(constant stimulation for two weeks). Exploratory and anxiety-like behaviors were  
evaluated using the open field test before and after stimulation. Tissue samples of the prefrontal  
cortex(PFC) were processed using Western blot analysis of markers of noradrenergic activity  
that included the noradrenergic synthesizing enzyme tyrosine hydroxylase(TH).  Analysis of  
tissue levels for catecholamines was achieved using high performance liquid chromatography.   
Finally, morphological properties of cortical pyramidal neurons were assessed using Golgi-cox  
staining.   
 
Results: Subjects undergoing intermittent and chronic stimulation of the NAcc exhibited an  
increase in exploratory behavior and reduced anxiety-like behaviors.TH expression levels were  
decreased in the PFC following intermittent and continuous DBS, and dopamine and  
norepinephrine levels were decreased following chronic stimulation. Golgi-Cox staining  
indicated that DBS increased the length of apical and basilar dendrites in pyramidal neurons of  
the PFC.  
 
Conclusion: DBS induces behavioral improvement as well as neurochemical and  
morphological alterations in the PFC that demonstrate changes within the circuitry of the brain  
different from the target area of stimulation. This observed dendritic plasticity may underlie the  
therapeutic efficacy of this treatment. 
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INTRODUCTION 
Deep brain stimulation (DBS) is a neurosurgical method that involves a lead or electrode 
being placed in a selected region of the brain 
1
. It is a reversible procedure that allows an 
adjustable treatment tailored to the patient. It has become a safe and effective treatment in 
various neurological disorders including Parkinson’s disease and essential tremor 2 3; 4.  More 
recently, this approach has been applied for the treatment of obsessive-compulsive disorder, 
epilepsy, and depression 
4
. 
Depression is a major cause of disability worldwide 
9
 and accounts for more than $83 
billion in domestic costs in the US alone 
10
. Lifetime prevalence varies widely, from 3% in Japan 
to 17% in the US; however, in most countries, the number of people who suffer from depression 
at one time in their lives falls within an 8–12% range 11; 12. Most patients are treated with 
antidepressant medications and some with psychotherapy or counseling. A minority is treated 
with electroconvulsive therapy 
13
. 
The role of the prefrontal cortex is important in understanding the nucleus accumbens 
and its circuitry. It has been shown that the nucleus accumbens core is involved in addiction and 
drug behavior and the nucleus accumbens shell (NAccS) is involved in pleasure, fear behavior, 
and food intake. 
27; 28; 29
 The nucleus accumbens has intricate connections with the prefrontal 
cortex and limbic system. It is these connections that are thought to be involved in the underlying 
symptomatology seen in depression. Therefore, DBS to the nucleus accumbens is a potential 
target in the treatment of depression and its effects on the prefrontal cortex become of interest. 
Animal models of epilepsy have benefited from stimulation of the subthalamic nucleus, 
substantia nigra and anterior thalamus 
5; 6; 7
.  Rats maintained on a high fat diet, as a model of 
obesity, experienced significant and sustained weight loss following continuous stimulation of 
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the lateral hypothalamic nucleus 
8
.  However, despite potential advances and therapeutic benefits 
of DBS, the cellular basis for the efficacy of this treatment remains elusive. Thus, studying the 
impact of DBS in pre-clinical models is important in establishing mechanisms underlying 
potential therapeutic improvements. 
The Wistar-Kyoto rat strain has been shown to be a useful preclinical model exhibiting a 
depressive and anxious-like phenotype 
14; 15; 16
.  This strain exhibits hormonal 
14; 17
 and 
behavioral 
15; 16
 abnormalities consistent with a depressive and anxious phenotype.  Several 
studies have demonstrated differing responses to antidepressants, as well as deficits in reward 
behavior and changes in hormonal levels in this strain 
18; 19; 20
.  
While DBS has been theorized to work by various mechanisms 
21; 22
 neuroplasticity is a 
potential mechanism by which DBS results in therapeutic improvements 
23
. Neuroplasticity, also 
known as brain plasticity can be defined as changes that occur in organization of the brain as a 
result of experience 
24
. Areas related to memory formation, such as the hippocampus and dentate 
gyrus are highly plastic and produce new neurons in a continuous fashion into adulthood 
24
. It 
has been shown that changes in long-term potentiation of cells induced by high-frequency 
stimulation of the subthalamic nucleus is a mechanism that determines the effectiveness of DBS 
in the treatment of Parkinson’s disease 25. Thus, this study aimed to show a relationship between 
DBS-induced changes in behavior with potential neurochemical and morphological changes. 
Owing to the importance of  the NAcc in regulating motivated behaviors and mood 
control 
26; 27; 28; 29
, the hypothesis that DBS of this region may be relevant in the treatment of 
depression was tested in the present study.   Behavioral studies were conducted following 
stimulation of the NAcc and subsequently neurochemical and morphological changes were 
assessed in the prefrontal cortex (PFC).    
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MATERIALS AND METHODS 
Animals 
The animal procedures used were approved by the Institutional Animal Care and Use 
Committee at Thomas Jefferson University and conform with the National Institutes of Health 
Guide for the Care and Use of Laboratory Animals.  Seventy nine adult male Wistar-Kyoto 
strain (250-275g; Charles River Laboratories International, Inc., Wilmington, MA) were used in 
the present study. Rats were caged individually on a 12-h light schedule (lights on at 0700) in a 
temperature-controlled (20 ºC) colony room. Food and water was made freely available. Rats 
were allowed to acclimate to the animal housing facility for several days prior to the onset of the 
study. All efforts were made to utilize only the minimum number of animals necessary to 
produce reliable scientific data, and experiments were designed to minimize any animal distress.   
Study Design  
All rats were randomly divided into three experimental groups (15 rats per group). Each 
rat underwent behavorial testing via an open-field prior to implantation. For the sham stimulation 
group, animals were sedated and underwent surgery with implantation of the electrode with no 
stimulation. For the intermittent group, animals were administered stimulation for the same 
3hrs/day for two weeks (14 days). The stimulation was turned on daily from 8am until 11am 
each day of the 14 day period. For the chronic group, animals were administered constant 
stimulation for two weeks (14 days). Chronic stimulation occurred 24 hours per day for the full 
14 days. They underwent behavioral evaluation post stimulation period, and were then exposed 
to isoflurane and euthanized by decapitation. Brains were removed and used for protein 
extraction and analysis.  
DBS Implantation 
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Each rat underwent stereotactic placement of a 0.25mm bipolar stimulating electrode 
(Plastics One Products) on the right side. Rats were initially anesthetized with a combination of 
ketamine hydrochloride (100 mg/kg) and xylazine (2mg/kg) in saline and placed in a stereotaxic 
apparatus for surgery. Anesthesia was supplemented with isoflurane (Abbott Laboratories; 0.5-
1.0%, in air) via a specialized nose cone affixed to the sterotaxic frame (Stoelting Corp.). The 
electrodes were placed via the coordinates determined by the Paxinos and Watson rat brain atlas 
(1.5mm anterior from bregma, 0.8mm medial/lateral, -7.4mm ventral from the top of the skull). 
The electrode was secured using dental cement and the incision was closed using staples. 
Each rat was allowed a 7-day recovery period after implantation. After this period they 
underwent stimulation via a continuous stimulus generator (Medtronic Screener Model 3638). 
The stimulation parameters were frequency 120Hz, pulse width 200msec, and strength 2 volts. 
The rats in the control group were connected to the generators which were not turned on. 
Open field test  
The open field was a square arena consisting of plexiglass walls and floor, measuring 
43.2cm x 43.2 cm x 30.5 cm. Rats were placed in the testing room 1 hour prior to behavioral 
tests. The behavioral analysis pre- and post-stimulation was kept constant by ensuring that the 
same testing room, same lighting and analysis was performed during the same time period of the 
day, by the same observer who was blinded to the experimental groups. The behavioral test post-
stimulation was done three hours after the last stimulation for both intermittent and chronic DBS. 
The open field test was utilized to evaluate the exploratory, anxiety, and depression-like 
behavior of the rats. Rats were placed in the open field test and recorded by the observer. They 
were observed for a 5-minute period in which their activity was measured based on the amount 
of quadrant changes and time spent on their hind legs as a marker of exploratory behavior or 
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locomotor activity. Crossing of midline was also analyzed and used as a marker of anxiety based 
on the difference of the rat spending time in either the periphery or center of the field test. 
 
 
Histology 
Following the stimulation period and final behavioral analysis the rats were immediately 
euthanized. The brain tissue was rapidly harvested for protein extraction and analysis. The 
electrode track was stained with Cresyl violet to confirm accurate placement of the electrode. 
The placement of the electrode targeted the NAcc at antero-posterior level that corresponded to 
Figure 12 of the brain atlas of Paxinos and Watson 
30
 (Figure 1). Rats that did not show optimal 
placement of the electrode were not included in the analysis. 
Brain Harvesting 
 The PFC extends from the rostrocaudal segment of the cerebral cortex and is located at a 
level 5.2 mm anterior to bregma and extends  3.3 posterior to bregma 
30
. Anatomically forming 
the anterior part of the forebrain, the PFC is bounded medially by the median plane dividing the 
cerebral lobes, ventrally by the medial orbital cortex (5.2 mm anterior to bregma - 3.2 mm 
anterior to bregma), dorsal peduncular cortex (3.2 mm anterior to bregma - 2.2 mm anterior to 
bregma) or corpus callosum (1.7 mm anterior to bregma - 3.3 mm posterior from bregma) and 
caudally by the occipital area 
30
. In the present study, the PFC was microdissected 
(approximately covering the PFC area at a level 3.7 mm anterior to bregma extending at a level 
1.7 posterior to bregma). 
Protein extraction  
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Brain tissue was rapidly removed from each animal and put on ice following the final 
behavioral analysis. Using a trephine, the prefrontal brain region was microdissected from each 
animal. The PFC was homogenized with a pestle and extracted in radioimmunoprecipitation 
assay lysis buffer (Santa Cruz Biotechnology) on ice for 20 min. Lysates were cleared by 
centrifugation at 13,000 rpm for 12 min at 41°C. Supernatants or protein extracts were diluted 
with an equal volume of Novex 2
®
 tris glycine sodium dodecyl sulfate sample buffer (Invitrogen) 
containing dithiothreitol  (Sigma-Aldrich Inc.). Protein concentrations of the undiluted 
supernatants were quantified using the bicinchoninic acid protein assay reagent (Pierce, 
Rockford, IL).  
Western blot analysis 
Cell lysates containing equal amounts of protein were separated on 4–12% tris-glycine 
polyacrylamide gels and then electrophoretically transferred to Immobilon-P polyvinylidene 
fluoride membranes (Millipore). Membranes were incubated in mouse anti-TH (Immunostar 
Inc.) primary antibody overnight and then in alkaline phosphatase-conjugated secondary 
antibodies for 30 min to probe for the presence of proteins using a Western blotting detection 
system (Western Breeze Chemiluminescent Kit; Invitrogen). Following incubation in a 
chemiluminescent substrate (Western Breeze Chemiluminescent Kit), blots were exposed to X-
OMAT AR film (Kodak) for different lengths of time to optimize exposures. TH was readily 
detected by immunoblotting in rat PFC extracts. TH immunoreactivity was visualized as a single 
band that migrates at approximately 60kDA. Blots were incubated in stripping buffer (Restore 
Stripping Buffer, Pierce) to disrupt previous antibody-antigen interactions and then re-probed 
with β-actin (1:5,000, Sigma-Aldrich Inc.) with 1-hour incubation to ensure proper protein 
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loading. The density of each band was quantified using Un-Scan-It blot analysis software (Silk 
Scientific Inc.). TH was normalized to β-actin immunoreactivity on each respective blot.  
High Pressure Liquid Chromatography 
Following the final behavioral analysis, PFC was sonicated in 1 ml of 0.1 M perchloric 
acid. A 100 µl aliquot of the sonicated material was stored at 80°C for protein determination 
using Pierce BCATM Protein Assay Kit (Thermo Scientific). The supernate was collected from 
centrifugation of the sonicated material at 13,000 g for15 min and stored at 70 °C until 
catecholamine extraction was performed. Catecholamines were extracted by alumina extraction 
from 100 µl of the sonicated supernate as previously described 
31
. The eluted catechols were 
filtered through 0.22 Millex®GV syringe driven filter and detection was performed with the 
ESACoulochem II electrochemical detector (conditioning cell set at_350 mV, electrode 1 of 
analytical cell set at 90 mV, electrode2 of analytical cell set at _300 mV) (ESA). Phenomonex 
reverse phase c18 Gemini column (150_4.6 mm, 3_C, 110 A) (Phenomonex) and 
ScientificSoftware Inc. were used for data collection and analysis. The catecholamines, 
norepinephrine and dopamine were measured in the PFC. Catecholamine values were expressed 
as ng catecholamine/mg protein. Data were adjusted to percent control, and values were 
expressed as the average percent change from control ± SEM. Experimental data were analyzed 
by using the computer program GraphPad Prism (v. 5.0, GraphPad Software Inc.).  
Golgi impregnation and morphological analysis 
The brains were prepared using the FD Rapid Golgi Stain kit (FD Technologies (FD 
Neurotechnologies). Brains were placed in 20 ml Golgi-Cox solution (potassium dichromate, 
mercuric chloride and potassium chromate), where they were stored in the dark for 14 days. 
After this incubation, sections containing PFC were obtained using a freezing microtome (100 
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µm; Micron HM550 cryostat; Richard-Allan Scientific) mounted onto gelatinized slides and 
coverslipped. Individual neurons and their processes were visualized at x100 using camera 
lucida. Dendritic length was measured in triplicate using National Institutes of Health Image J 
(National Institutes of Health).   
Data Analysis 
Statistical analyses were performed using Graph Pad In Stat software (Graph Pad 
Software Inc.). For comparison of two groups in experiments, unpaired Student’s t-test was used 
to analyze data. One way-analysis of variance followed by post-hoc Newman-Keuls multiple 
comparisons test was used to analyze differences among three independent groups. Averages are 
expressed as means ± SEM. Differences were considered to be statistically significant when the 
probability value was < 0.05 
 
 
 
 
 
 
 
 
 
RESULTS 
DBS increases exploratory behavior and reduces anxiety-like behavior in an open field 
paradigm 
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To investigate whether DBS of the NAcc exerts an effect on depression and anxiety-like 
behaviors in rats, an assessment of behavior in the open field test was carried out. Open-field is a 
traditional paradigm used to assess locomotor or exploratory activity and anxiety-like behaviors 
wherein the inherent drive to explore a novel environment is opposed by the tendency to stay in 
protective areas. The rodent that exhibits anxiety-like behaviors avoids the unsafe and aversive 
space of the inner fields and thus spends more time in the outer perimeter of the field 
32
. Data 
obtained was based on the amount of quadrant changes and time spent on their hind legs as a 
marker of exploratory behavior or locomotor activity. Crossing of midline was also analyzed and 
used as a marker of anxiety based on the difference of the rat spending time in either the 
periphery or center of the field test. 
Shown in Table 1 is the average value (n = 15 rats per group) of each criterion analyzed 
in the open field test. This data is used to determine the exploratory nature of the rat as well as 
the level of anxiety of the rat during the test as a marker of depressive and anxiety-like 
behaviors. Assessment was conducted for 5-minute intervals pre and post stimulation. 
The behavioral data obtained from the control rats that received sham stimulation of the 
NAcc showed a significant decrease (P < 0.001) in all parameters analyzed when compared to 
pre-stimulation time point. Specifically, these subjects exhibited an increase in depression and 
anxiety-like behaviors that were manifested as a decrease in locomotor and exploratory 
behaviors in the open field test, as well as decrease crossing of midline (Table 1). Wistar-Kyoto 
rats that received DBS of the NAcc showed significant increases (P < 0.05) in exploratory 
behavior and crossing of midline indicative of a reduction in depression and anxiety-like 
behavior.  
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When comparing the three treatment groups to each other, baseline behavior during pre-
implantation showed no significant difference across the treatments. Post-implantation data 
showed a significant difference across all groups (P < 0.01) with the largest difference seen when 
comparing either the intermittent or chronic stimulation group to the control group. Control rats 
continued to exhibit depression-like and anxiety- like behaviors compared to either the 
intermittent or chronic stimulated groups (P < 0.01). There was a significant decrease (P < 0.01) 
in quadrant changes, as well as less time spent on hind legs (P < 0.001). In addition, the sham-
stimulated control group demonstrated almost no tendency to cross the midline and there was a 
significant decline (P < 0.001) in exploratory behavior and an increase in anxiety. Intermittent 
and chronic stimulation groups showed a significant increase (P < 0.01) in quadrant changes and 
time spent on hind legs, demonstrating increased exploratory behavior when compared to pre-
implantation and sham-stimulated controls. There was also a significant increase (P < 0.001) in 
crossing midline indicating less anxiety. There was a larger change observed in the chronic 
stimulation group than with the intermittent stimulation group when comparing to all pre-implant 
values. These data demonstrate that there was a more significant behavioral response to 
treatment with chronic stimulation as opposed to intermittent stimulation. 
DBS alters levels TH expression in the prefrontal cortex 
 In the present study, the PFC was microdissected (approximately covering the PFC area 
at a level 3.7 mm anterior to bregma extending at a level 1.7 posterior to bregma). Tyrosine 
hydroxylase protein expression following DBS was assessed using Western blot analysis. 
Prefrontal cortex extracts from rats (n = 4 rats per group) that were euthanized following chronic 
stimulation group showed a significant decrease  (P < 0.05) in TH expression levels compared to 
intermittent stimulation group and sham-stimulated control (Figur e 2). There was also a 
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decrease in TH expression level following intermittent stimulation. However, it has not reached a 
statistically significant difference.  
DBS alters levels NE and DA expression in the prefrontal cortex 
DA and NE content in the PFC following chronic stimulation were assessed using HPLC. 
DA and NE were chosen for testing secondary to being downstream in the biosynthetic pathway 
for catecholamine’s and should be directly correlated with the effects observed with TH (Figure 
3). This aimed to determine if the decrease levels of the converting enzyme TH following 
chronic stimulation observed on Western blot analysis (Figure 2) correlated with a decrease in 
the production of its neurotransmitters in the biosynthetic pathway for catecholamines. Statistical 
analysis showed that PFC extracts from rats (n = 4-5 rats per group) that were euthanized 
following chronic stimulation demonstrated a significant decrease in the content of NE (P < 
0.05) and DA (P < 0.05) compared with sham-stimulated control (Figure 4).   
DBS increases dendritic length in layer V pyramidal cells in the prefrontal cortex      
Statistical analysis showed that intermittent and chronic stimulation for 14 days in the 
NAcc significantly increased apical (P < 0.01) and basilar (P < 0.01) dendritic length in the layer 
V pyramidal cells in the PFC (Figure 5). However, there was no significant difference observed 
in the number of basilar dendritic branches in the three groups studied. Apical dendritic length 
did not significantly differ between intermittent stimulation group and chronic stimulation group. 
Figure 6 presents representative camera lucida drawings of Golgi-cox stained neurons found in 
PFC in sham-stimulated, intermittent and chronic stimulation groups. These drawings clearly 
illustrate that the length of the dendrites and the length of the branches have increased with both 
intermittent and chronic stimulation as compared to the sham-stimulated control group. Deep 
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brain stimulation of the nucleus accumbens therefore influences dendritic plasticity in the 
prefrontal cortex of Wistar-Kyoto rats.  
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DISCUSSION 
The present study provides the first in vivo evidence that DBS of the NAcc reduces 
anxiety and depression in an animal model via an open field test. These results are consistent 
with a recent report demonstrating that DBS in the NAcc can reduce anhedonia in patients with 
treatment-resistant depression 
33
. Moreover, DBS of the NAcc induces neurochemical and 
morphological modifications in the PFC that may partly explain the neural mechanism by which 
DBS exerts its effects and that the locations of changes in the brain circuitry are yet to be 
defined. This study set out to correlate behavioral changes directly with structural changes within 
this circuit. By establishing changes in the circuit it can be demonstrated that the effects of DBS 
may be upstream or downstream from its target and cause neuroplasticity and not be directly at 
the area of stimulation. DBS may have either excitatory or inhibitory effects which may be 
leading to changes in a different location of the brain.  
 
Methodological considerations 
There are inherent caveats that exist with respect to Western blot analysis experiments. 
These caveats include the accuracy of sampling of the region of interest and the comparison of 
equal protein quantities across treatment groups. In order to circumvent the variability in tissue 
excision, a single investigator obtained the brain samples for each experiment. Moreover, to 
ensure equivalent loading of protein, blots were reprobed with β-actin and results were 
normalized to this internal standard. β-actin expression was comparable across treatment groups 
examined. 
Some effects may not have been visualized, such as the absence of change in TH 
expression levels with intermittent stimulation that could be attributed to the short stimulation 
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and observation in the conduct of DBS. The stimulation period only lasted for two weeks and 
this may not have been long enough to demonstrate all the changes that were occurring. This 
could partly explain the similar dendritic branching among groups studied. It would also be 
interesting to examine how long these effects on behavior, neurochemical and structural changes 
would last after a period of stimulation. Shi et al. suggested that there may be highly plastic 
neural networks that may undergo lasting effects with DBS 
27
 
 The NAcc as target for DBS-treatment  
The NAcc is known to integrate limbic and cortical inputs which then send projections to 
the basal forebrain and in turn sends back projections into the PFC 
34; 35
. Neurochemical 
manipulation of the NAcc has been linked to changes in pleasure 
28; 36
. Anhedonia which is the 
inability to experience pleasure from previously pleasurable activities, is a prominent clinical 
feature of depression 
37; 38
. DBS via bilateral electrodes placed in the NAcc in patients suffering 
from extremely resistant forms of depression  that did not respond to pharmacotherapy, 
psychotherapy and electroconvulsive therapy had significantly reduced anhedonia 
33
. While 
effectively reducing anhedonia, DBS of NAcc did not produce any neurological and 
psychological side effects 
33
. Therefore, DBS of the NAcc can be a potential target for the 
treatment of depression to alleviate the symptoms of anhedonia.  
DBS in the NAcc reduces anxiety-like behavior and alters catecholamine levels in the 
prefrontal cortex.  
 Our present behavioral data are consistent with previous reports showing that Wistar-
Kyoto rats exhibit depressive-like behaviors 
14; 15; 16
. An increase in depression-like behaviors in 
control subjects most likely results from rats being individually housed throughout the 
experimental conditions. Previous data have shown that single rat housing is considered a mild 
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stress 
39
 indicating that sham stimulated rats may have experienced this mild stress that resulted 
in decreases in locomotor and exploratory behaviors. More importantly, our behavioral data 
support previous clinical reports on bilateral DBS of the NAcc which showed immediate effects 
on ratings of depression on patients with treatment-resistant depression 
33
. 
We specifically demonstrated in an open-field test that while sham-stimulated control rats 
continued to manifest signs of depression and anxiety, rats that received either intermittent or 
chronic DBS showed a significant reduction of depression and anxiety-like behaviors as 
evidenced by quadrant changes, time spent on hind legs, midline crossing, exploratory behavior 
and reduced anxiety when compared to pre-implantation and controls. There was a more 
significant behavioral response to treatment with chronic stimulation as opposed to intermittent 
stimulation. Control rats continued to be more depressed with age. The open field test is usually 
used to measure locomotor behavior and although useful in our experiment its interpretation of 
the behavior change is somewhat limited secondary to correlating behavioral change with 
depression and anxiety. That being said, the true significance of the behavioral data lies in that 
the control group worsened in all areas tested for behavioral analysis while the stimulation 
groups improved. This demonstrates that DBS of the NAcc did not only halt the progression of 
the disease process, but improved it, consistent with evidence showing that neuronal adaptation 
is disrupted in mood disorders and that treatments for depression would need to enhance 
neuroplasticity 
40
. The present study also determines whether the behavioral changes following 
stimulation of the NAcc lead to changes in neural circuits, specifically the PFC. 
It is anatomically established that NAcc receives afferent projections from PFC 
41; 42; 43
. 
The PFC is known for its vital role in a cognitive and behavioral processes including arousal, 
attention, cognition, motivation, working memory and vigilance 
44
. The release of 
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catecholamines, NE and dopamine, is related to arousal states that consequently have profound 
effects on cognitive and behavioral processes involving PFC functions 
45; 46
. The PFC is very 
sensitive to changes to neurochemical environment so that any minute changes in catecholamine 
generate profound effects on the activity of PFC 
47
. Indeed, the role of the medial PFC is 
important in understanding the NAcc and its circuitry therefore making it also important to 
understand the neuroadaptations in the PFC following DBS of NAcc.  
Using Western blotting and HPLC, the levels of TH, norepinephrine  (NE) and dopamine  
(DA), were determined, respectively, following DBS of the NAcc. Western blot analysis 
demonstrated a decrease in expression of TH in the PFC after both intermittent and chronic 
stimulation, although statistical significance was only observed in chronic stimulation. To 
determine if the decreased levels of the converting enzyme TH correlated with a decrease in the 
production of its neurotransmitters in the biosynthetic pathway for catecholamines, the levels of 
DA and NE were evaluated. The levels of DA and NE were significantly decreased in the PFC 
with chronic stimulation as compared to controls demonstrating a correlation with the decreased 
levels of TH. This was not observed in the intermittent stimulation group, as the levels of DA 
and NE mimicked that of the control group. This may be secondary to the less pronounced 
response in TH levels seen on the western blot analysis for intermittent stimulation. There may 
be a threshold in TH levels which needs to be breached before there are changes of levels in 
these neurotransmitters. It can also be hypothesized that this is why there was not as large a 
response in behavior changes in the intermittent stimulation group as compared to the chronic 
stimulation group.  
DBS in the NAcc induces neuroplasticity in the prefrontal cortex.  
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The results of the present study showed that neurochemical alterations were evident on 
the expression levels of TH, DA and NE. Whether these neurochemical changes lead to 
morphological changes in neuronal structure, dendritic growth and branching were examined as 
markers for neuroplasticity. As a fundamental mechanism of neuronal adaptation, neuroplasticity 
is altered in stress paradigm in animals. For instance, chronic restraint stress significantly 
reduced the length and number of branches of apical dendrites but not of basilar dendrites of the 
pyramidal neurons of lamina II-III of medial PFC 
48; 49
. Stress also caused atrophy of the 
hippocampal neurons 
50
. An evaluation with golgi- cox staining demonstrated that the length of 
the apical and basilar dendrites of the pyramidal neurons of layer V of medial PFC increased 
with both intermittent and chronic stimulation as compared to the control group. This data 
confirms the behavioral data in open-field where rats that received intermittent and continuous 
stimulation exhibited reduced depressive and anxiety-like behavior. Although, the neurochemical 
data were consistent with significant reduction in TH, NE and DA in PFC only in chronic but not 
in intermittent stimulation, it is likely that the reduction of TH, NE and DA, though not 
statistically significant may have efficiently induced behavioral changes and morphological 
changes in apical and basilar dendrites. Further investigation is needed to elucidate this data. 
Nevertheless, the present morphological data indicate that DBS of the NAcc influences dendritic 
plasticity in the PFC. 
CONCLUSION 
 Our present results highlight DBS of the NAcc as a potential treatment modality for 
depression. In addition, our results present DBS of the NAcc as a mechanism that induces 
defined neurochemical changes and structural dendritic changes in the PFC that demonstrates 
neuroplasticity in the circuitry of the brain. It was shown that the effects of DBS may not only be 
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at the area of stimulation or placement of the electrode, but can lead to changes either upstream 
or downstream in the circuits of the brain. This further solidifies the thought process that there 
are long term structural changes that are occurring with DBS. Understanding DBS, as well as the 
brain as a circuit may be a link to unlocking the brain’s ability to undergo neuroplasticity. The 
neurochemical alterations in the expression levels of TH, dopamine and norepinephrine, as well 
as the dendritic neuroplasticity observed in the cortical areas may underlie the behavioral 
changes following DBS of the nucleus accumbens shell. 
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Figure legends 
FIGURE 1. Brightfield photomicrograph of a representative coronal section showing the site of 
deep brain stimulation into the NAcc used for various experiments. Inset shows a schematic 
diagram adapted from the rat brain atlas of Paxinos and Watson (1988) showing the region 
targeted for the deep brain stimulation. Big arrow indicates the location where the electrode was 
placed. Asterisks indicate lateral ventricle. Small arrows indicate dorsal (D) and medial (M) 
orientation of the tissue sections. Scale bars = 100 m. 
FIGURE 2. Western blot analysis of tyrosine hydroxylase (TH) expression in the prefrontal 
cortex (PFC) following deep brain stimulation/sham stimulation of the NAcc of Wistar-Kyoto 
rats.TH expression in the PFC of the animals is expressed as a fold change from the control mean 
when the control equals 1.0 ± SEM. β-actin immunoblotting was used as a control to verify equal 
protein loading.TH was significantly decreased (P < 0.05) following continuous stimulation 
compared to the sham stimulation group. *P < 0.05 vs sham stimulation. 
FIGURE 3. Biosynthetic pathway for catecholamine 
FIGURE 4. Dopamine (DA) and norepinephrine (NE) levels in the prefrontal cortex of Wistar-
Kyoto rats are altered following deep brain stimulation/sham stimulation of the NAcc. Values are 
means ± SEM of four rats per group. * P < 0.05 vs sham stimulation. 
FIGURE 5. Mean dendritic length (µm) and number of dendritic branches in the NAcc of rats 
following brain stimulation/sham stimulation of the NAcc of Wistar-Kyoto rats. Values are 
means ± SEM of four rats per group. * P < 0.05 vs sham stimulation  
FIGURE 6. Representative camera lucida drawings of the NAcc following deep brain 
stimulation/sham stimulation of the NAcc of Wistar-Kyoto rats. 
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Table 1: Behavioral Analysis with an Open- Field Test 
 
 
 Quadrant Changes 
Time on Hind 
Legs(seconds) Cross Midline 
Control 24.3 ± 1.38  35.1 ± 2.35  1.1 ± 0.32 
Intermittant 19.9 ± 2.19  25.9 ± 4.20  1.3 ± 0.41 
Chronic 22.1 ± 2.0  31.9 ± 2.90  1.1 ± 0.30 
    
Post- Implantation    
Control 15.88 ± 1.37  21.56 ± 1.77  0.1 ± 0.09 
Intermittant 23.9 ± 3.06* 36.6 ± 6.61** 1.79 ± 0.53** 
Chronic 28.3 ± 1.91** 45.5 ± 4.89** 2.3 ± 0.51** 
    
*P < 0.01 **P < 0.001 compared with control  
    
Difference    
Control -8.42 -13.54 -1 
Intermittant 4 10.7 0.5 
Chronic 6.2 13.6 1.2 
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